Showing results (221-230 of 247) with videos related to

Sort By:
Pageof 25
Signal Transduction and Targeted Therapy|September 17, 2021
S19W, T27W, and N330Y mutations in ACE2 enhance SARS-CoV-2 S-RBD binding toward both wild-type and antibody-resistant viruses and its molecular basisFei Ye, Xi Lin, Zimin Chen, et al.
Cell Research|April 29, 2015
In-cell infection: a novel pathway for Epstein-Barr virus infection mediated by cell-in-cell structuresChao Ni, Yuhui Chen, Musheng Zeng, et al.
Cellular & Molecular Immunology|August 20, 2024
Engineered mitochondria exert potent antitumor immunity as a cancer vaccine platformJingwen Luo, Fei Mo, Zhe Zhang, et al.
International Journal of Biological Macromolecules|December 20, 2025
Modification of a SARS-CoV-2 spike-RBD targeting nanobody for pH-dependent binding and its chromatographic engineering for purification of WT and variant S-RBDs with mild elution conditionsXindan Zhang, Zimin Chen, Sheng Lin, et al.
Nature Communications|July 11, 2026
Conformational hijacking of lipoprotein transporter LolDF enables precision antimicrobial activity against Acinetobacter baumanniiJie Pang, Yawen Chen, Dengcheng Zhou, et al.
Cell Reports|November 5, 2025
CD94/NKG2A-Qa-1<sup>b</sup> axis as a key modulator of vaccine responsiveness in aging populationsLi Chen, Ziyi Bai, Dandan Wan, et al.
Theranostics|June 14, 2018
Negative regulation of cationic nanoparticle-induced inflammatory toxicity through the increased production of prostaglandin E2 via mitochondrial DNA-activated Ly6C<sup>+</sup> monocytesLi Liu, Yantong Liu, Bocheng Xu, et al.
Theranostics|September 20, 2019
Erratum: Negative regulation of cationic nanoparticle-induced inflammatory toxicity through the increased production of prostaglandin E2 via mitochondrial DNA-activated Ly6C<sup>+</sup> monocytes: ErratumLi Liu, Yantong Liu, Bocheng Xu, et al.
Medcomm|March 13, 2023
Heterologous vaccination with subunit protein vaccine induces a superior neutralizing capacity against BA.4/5-included SARS-CoV-2 variants than homologous vaccination of mRNA vaccineDandan Peng, Tingmei Zhao, Weiqi Hong, et al.
Nature Communications|February 14, 2026
Deficiency of lysosomal TMEM175 in myeloid macrophages exerts anti-tumor immunity via inflammasome and cross-presentation pathwayZiqi Zhang, Xue Li, Tianqi Lu, et al.
Pageof 25